parp inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
Published 1 year ago • 116 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
1:01
choosing the correct parp inhibitor for prostate cancer
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
4:05
presto study
-
9:53
parp inhibitors for prostate cancer with moshe ornstein, md
-
35:38
parp inhibitor combination regimens for prostate cancer management
-
1:21
combining a parp and pd-l1 inhibitor to treat prostate cancer
-
1:43
parp inhibitors for prostate cancer
-
2:38
parp inhibitors
-
1:24
luparp: 177lu-psma-617 and parp inhibitor combination for prostate cancer
-
11:49
brca & parp inhibitors: targeted chemotherapy | #markscholzmd #alexscholz @pcri
-
1:25
parp inhibitors: their applications and efficacy against prostate cancer
-
42:41
round-table discussion on parp inhibitor
-
1:39
challenges in the field of parpi treatment for mcrpc
-
4:12
parp inhibitors
-
16:22
role of parp inhibitors in prostate cancer
-
0:41
understand the adverse events of parp inhibitors
-
14:39
new fda approved parp inhibitor: talzenna (talazoparib) & xtandi | #markscholzmd #alexscholz #pcri
-
4:02
the emerging role of parp inhibitors in prostate cancer
-
38:47
parp inhibitors and their evolving role for the treatment of prostate cancer